Entering text into the input field will update the search result below

With the FDA showing once again that it is willing to ignore the recommendations of its own...

With the FDA showing once again that it is willing to ignore the recommendations of its own panels, investors in MELA Sciences ([[MELA]] +3.7%) will have some nervous days ahead of a final decision on the MelaFind, as the FDA clearly had concerns with this application.

Recommended For You

About SSKN Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
SSKN--
STRATA Skin Sciences, Inc.